WILMINGTON, North Carolina,
Sept. 29, 2015 /PRNewswire/
-- AAIPharma Services Corp. / Cambridge Major Laboratories,
Inc. (AAI/CML) has recently expanded its service capabilities to
offer two sites as options for placement of Disinfectant
Effectiveness/ Disinfectant Qualification (DE/DQ) studies. In order
to meet a high customer demand, provide regional support and
complement the existing services from the Edison, NJ, facility, AAI/CML now offers DE/DQ
at its St. Louis, MO
facility. These studies satisfy the requirements of USP
<1072> Disinfectants and Antiseptics and support
clients with their needs to comply with cGMP 21 CFR 211.67,
Equipment Cleaning and Maintenance.
Logo - http://photos.prnewswire.com/prnh/20150806/256637LOGO
The expansion allows AAI/CML to further support sterile and
non-sterile product manufacturers in the development and
qualification of disinfectant programs to prevent microbial
contamination through pharmaceutical ingredients, process water,
packaging components, manufacturing environment, process and
manufacturing equipment.
"We are excited to expand our disinfectant qualification systems
to our St. Louis facility and
provide the kind of robust systems needed to prevent microbial
contamination in the manufacture of pharmaceutical products,"
stated Ted Dolan, Chief Operating
Officer. "This added capability allows us to offer more
options for regional proximity and flexibility for manufacturing
and testing with AAI/CML from both our St. Louis, MO and Edison, NJ sites."
About AAIPharma Services Corp. and Cambridge Major
Laboratories, Inc.
AAIPharma Services Corp. and Cambridge Major Laboratories, Inc.
have joined to form a world-class supplier of comprehensive
pharmaceutical development and manufacturing services. With
seven sites across the globe, our combined capabilities include API
development and manufacturing, solid state chemistry, formulation
development, analytical development and testing services, clinical
and commercial finished dosage form manufacturing (solid dose and
parenteral), packaging, and stability services. The family of
companies is in the portfolio of American Capital, Ltd. (NASDAQ:
ACAS). Contact us for all your drug development and manufacturing
needs at www.aaipharma.com and www.c-mlabs.com.